Previous month:
November 2011
Next month:
January 2012

ISHRS News Release: 19TH ANNUAL SCIENTIFIC MEETING IN ANCHORAGE, ALASKA,

 

INTERNATIONAL SOCIETY OF HAIR RESTORATION SURGERY MAINTAINS SAFETY AND EFFICACY OF PROPECIA (FINASTERIDE 1MG) FOR MALE HAIR LOSS IS BACKED BY PROVEN SCIENTIFIC DATA Task force formed to study reports of sexual dysfunction in some men taking Propecia for hair loss

GENEVA, IL. – December 13, 2011.  The International Society of Hair Restoration Surgery (ISHRS) – the world’s leading medical authority on hair loss and hair restoration – cautions that recent anecdotal reports of persistent sexual dysfunction by some men who have used finasteride 1mg (Propecia) to treat hair loss should not define the safety and effectiveness of this drug.  Propecia is the only oral medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of hair loss in men.

The ISHRS is the primary organization for doctors who specialize in the treatment of hair loss and hair transplantation. Combined, they have the most experience with treating hair loss with the currently FDA-approved medications.
All of us who treat hair loss know that losing hair can affect one's self-esteem and self-image. If hair loss continues (with or without treatment) this can sometimes lead to anxiety and depression--both of which are commonly known to lower sex drive and hamper sexual performance. It is the opinion of some physicians that if the hair loss is not successfully treated, the risk of decreased libido and erectile dysfunction can increase. An interesting note: more patients left the Propecia clinical trials complaining of decreased sex drive who were taking PLACEBO (sugar pill) than the actual medication itself!
To reiterate our observations at Bauman Medical Group: In over 8,000 patients treated with Propecia 1mg, we have never seen a case of persistent side-effects due to the medication. ---Dr. Alan J. Bauman